PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY BOWEL DISEASE COMPRISING MOLLUGIN OR ITS ANALOGUES

摘要

PURPOSE: A pharmaceutical composition containing mollugin or mollugin derivative for treating inflammatory bowel disease is provided to suppress monocyte attachment and transcription factor NF-kappa B and to reduce inflammatory cytokine expression. CONSTITUTION: A pharmaceutical composition for treating inflammatory bowel disease contains 0.01-50 weight parts of mollugin or mollugin derivative of chemical formulas 1-4 as active ingredients. A health food for treating inflammatory bowel diseases contains mollugin or mollugin derivative of chemical formulas 1-4 as active ingredients.